Blog

Rahul Banerjee: Nice analysis of Australia/New Zealand multiple myeloma with emphasis on CRAB vs SLiM

Photo collage of Rahul Banerjee & Hang Quach

Jul 9, 2024, 06:35

Rahul Banerjee: Nice analysis of Australia/New Zealand multiple myeloma with emphasis on CRAB vs SLiM

Rahul Banerjee, Assistant Professor at UW Medicine, made the following post on X:

“Now in The British Journal of Haematology – nice analysis of Australia/New Zealand multiple myeloma patients by Hang Quach et al, emphasis on CRAB vs SLiM-presenting myeloma.

PFS better with SLiM-only as expected, but PFS2 and OS also better: less resistant relapses when clones treated at earlier stages?”

Read further.
Source: Rahul Banerjee/X

Australia British Journal of Haematology cancer Cancer research CRAB criteria Hang Quach Hematology multiple myeloma New Zealand OncoDaily Oncology OS PFS Rahul Banerjee Research SLiM criteria UW Medicine

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Agenus and Tanner Pharma Partner to Expand Global Access to BOT/BAL

Special Coverage